The growth and potential of human antiviral monoclonal antibody therapeutics
Top Cited Papers
- 7 December 2007
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 25 (12) , 1421-1434
- https://doi.org/10.1038/nbt1363
Abstract
Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.Keywords
This publication has 169 references indexed in Scilit:
- Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virusProceedings of the National Academy of Sciences, 2007
- Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibodyVirology, 2007
- The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus InfectionPublished by Elsevier ,2007
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007
- Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodiesVirology, 2007
- Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenavirusesNature, 2007
- Isolation of anti-CD22 Fv with high affinity by Fv display on human cellsProceedings of the National Academy of Sciences, 2006
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004